Project Oncology®

156 Epizód

1. Managing Immune-Related Adverse Events With Immunotherapies

   Közzétéve: 2024. 05. 03.
2. Optimizing First-Line Immunotherapy for Recurrent or Metastatic HNSCC

   Közzétéve: 2024. 05. 03.
3. Overcoming Barriers to Equitable Care in HNSCC

   Közzétéve: 2024. 05. 03.
4. Indications to Switch Therapies for Myelofibrosis Patients

   Közzétéve: 2024. 04. 23.
5. Managing Myelofibrosis with a Patient-Centered Approach

   Közzétéve: 2024. 04. 17.
6. Anemia and Myelofibrosis: Optimizing Diagnosis, Treatment, and Management Strategies

   Közzétéve: 2024. 04. 15.
7. Exploring the Significant Presence of Anemia in Myelofibrosis

   Közzétéve: 2024. 04. 15.
8. Navigating Myelofibrosis Treatment Complexities to Optimize Care

   Közzétéve: 2024. 04. 09.
9. Maximizing B-Cell Lymphoma Outcomes with CAR T-Cell Therapy and Personalized Care

   Közzétéve: 2024. 04. 04.
10. B-Cell Lymphoma Care: Overcoming Challenges in the Second-Line Setting

    Közzétéve: 2024. 04. 04.
11. Managing B-Cell Lymphomas in the Second-Line Setting: The Role of CAR T-Cell Therapy

    Közzétéve: 2024. 04. 04.
12. Treating mCRPC with Lutetium-177 and Radium-223: Expert Insights

    Közzétéve: 2024. 03. 13.
13. mCRPC Care: Reducing Progression Risk by Combining Enzalutamide and Talazoparib

    Közzétéve: 2024. 02. 20.
14. Prostate Cancer Research: Why Disparities Exist in Mortality and Trial Access

    Közzétéve: 2024. 02. 15.
15. Prostate Cancer Care: Improving Hormonal Therapy Sequencing Post-Treatment Intensification

    Közzétéve: 2024. 02. 09.
16. Novel Immune Checkpoint Strategies in Non-Small Cell Lung Cancer Care

    Közzétéve: 2024. 02. 09.
17. The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey

    Közzétéve: 2024. 01. 29.
18. Emerging Strategies in Multi-Cancer Early Detection

    Közzétéve: 2024. 01. 29.
19. Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU

    Közzétéve: 2024. 01. 25.
20. ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer

    Közzétéve: 2024. 01. 25.